The cardiac monitoring devices market in APAC is expected to grow from US$ 6,089.21 million in 2021 to US$ 9,720.98 million by 2028; it is estimated to grow at a CAGR of 6.9% from 2021 to 2028.
APAC is the fastest-growing regional market for cardiac monitoring devices. The market in APAC is segmented into and China, India, Japan, South Korea, Australia, and the Rest rest of APAC are the major contributors to the market in this region. The cardiac monitoring devices market is fueled by the rising prevalence of cardiovascular diseases, an surging ageing population that is more susceptible to coronary heart disease, growing technical advancements in cardiac monitoring devices that reduce the risk of infection risk, and increasinged device efficiency of devices. One of the leading causes of lung cancer and heart disease is smoking. Each year, over 1 million cardiovascular deaths occur in the Asia-Pacific areaAPAC, according to the World Health Organization (WHO). Because ofOwing to the expanding burden of cardiac diseases and the necessity to limit mortality rates by early detection and treatment of cardiovascular diseases (CVD) with the use of cardiac monitoring devices, the diagnosis rate of diagnosis of cardiovascular diseasesCVD is increasing over time.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC cardiac monitoring devices market in the coming years. The APAC cardiac monitoring devices market is expected to grow at a good CAGR during the forecast period. APAC Cardiac Monitoring Devices Market Revenue and Forecast to 2028 (US$ Million)
APAC Cardiac Monitoring Devices Market Segmentation
APAC cardiac monitoring devices market is segmented into type, product type, application, end user, and country. Based on type, the APAC cardiac monitoring devices market is segmented into cardiovascular devices, multi-parameter ECG monitors, patient monitoring devices, ambulatory cardiac monitoring, and cardiac monitors. In 2020, the cardiovascular devices segment held the largest share of the market. Based on product type, the APAC cardiac monitoring devices market is segmented into portable monitor, smart wearable monitor, and standard monitor. In 2020, the standard monitor segment held the largest share of the market. Based on application, the APAC cardiac monitoring devices market is segmented into coronary heart diseases, sudden cardiac arrest, stroke, arrhythmia, congenital heart diseases, heart failure, pulmonary hypertension, heart function (HF/LVEDP), pulmonary artery pressure (PA), and others. The coronary heart diseases segment held the largest market share in 2020, and it is further expected to be the largest shareholder in the market by 2028. Based on end user, the APAC cardiac monitoring devices market is segmented into hospitals, ambulatory surgery centers (ASCs), and clinics. The hospitals segment held the largest market share in 2020. Based on country, the APAC cardiac monitoring devices market is segmented into Australia, China, India, Japan, South Korea, and the rest of APAC. Furthermore, Abbott; AliveCor, Inc; Amiitalia; Asahi Kasei Corporation; Bionet America, Inc.; Biotronik, Inc.; Boston Scientific Corporation; BTL; GE Healthcare; Hill-Rom Holdings, Inc.; Infinium Medical; Koninklijke Philips N.V.; LivaNova PLC; Medtronic; MicroPort Scientific Corporation; Mortara Instruments; Nihon Kohden Corporation; SCHILLER Healthcare India Pvt. Ltd; and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. are among the leading companies in the APAC cardiac monitoring devices market.